Company Quick10K Filing
GB Sciences
10-Q 2020-06-30 Filed 2020-09-02
10-K 2020-03-31 Filed 2020-08-28
10-Q 2019-12-31 Filed 2020-02-18
10-Q 2019-09-30 Filed 2019-11-15
10-Q 2019-06-30 Filed 2019-08-15
S-1 2019-05-03 Public Filing
10-K 2019-03-31 Filed 2019-07-15
S-1 2019-03-12 Public Filing
10-Q 2018-12-31 Filed 2019-02-19
10-Q 2018-09-30 Filed 2018-11-14
S-1 2018-09-20 Public Filing
10-Q 2018-06-30 Filed 2018-08-14
10-K 2018-03-31 Filed 2018-06-29
10-Q 2017-12-31 Filed 2018-02-14
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-14
10-K 2017-03-31 Filed 2017-07-12
10-Q 2016-12-31 Filed 2017-02-14
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-K 2016-03-31 Filed 2016-07-14
10-Q 2015-12-31 Filed 2016-02-16
10-Q 2015-09-30 Filed 2015-11-18
10-K 2015-03-31 Filed 2015-06-29
10-Q 2014-12-31 Filed 2015-02-17
10-Q 2014-06-30 Filed 2014-08-14
10-K 2014-03-31 Filed 2014-06-27
10-Q 2013-10-01 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-19
10-K 2013-03-31 Filed 2013-07-15
10-Q 2012-12-31 Filed 2013-02-19
10-Q 2012-09-30 Filed 2012-12-13
10-Q 2012-06-30 Filed 2012-08-20
10-K 2012-03-31 Filed 2012-07-16
10-Q 2011-12-31 Filed 2012-02-14
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-22
10-K 2011-03-31 Filed 2011-07-11
10-Q 2010-12-31 Filed 2011-02-14
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-16
10-K 2010-03-31 Filed 2010-07-14
10-Q 2009-12-31 Filed 2010-02-22
8-K 2020-08-18 Other Events
8-K 2020-06-29 Other Events
8-K 2020-05-12
8-K 2020-04-23
8-K 2020-04-09
8-K 2020-03-24
8-K 2019-11-27
8-K 2019-11-19
8-K 2019-11-07
8-K 2019-10-23
8-K 2019-09-12
8-K 2019-09-01
8-K 2019-08-15
8-K 2019-08-10
8-K 2019-07-26
8-K 2019-06-17
8-K 2018-09-21
8-K 2018-09-21
8-K 2018-04-06
8-K 2018-03-07
8-K 2018-02-23

GB Sciences Financials

GBLX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Sierra Monitor (SRMC) 23,849 59% 29.1 3% 11,778 2,813 17,068 10,151 301 742 21,593
Heritage Global (HGBL) 23,776 0% 5.4 15% 22,548 11,416 20,597 0 3,322 3,704 19,875
Standard Metals Processing (SMPR) 23,655 -790.6 -24% 3,905 20,231 0 0 -941 -30 23,653
Bionik Laboratories (BNKL) 23,610 7.9 6% 35,234 3,260 0 1,857 2,167 2,391 18,935
Znergy (ZNRG) 23,572 14% -7.3 -336% 1,025 1,831 1,222 173 -3,443 -3,246 23,566
Draper Oakwood Technology Acquisition (DOTA) 23,547 -218.6 -0% 58,936 53,936 0 0 -160 -108 23,539
Barington/Hilco Acquisition (BHAC) 23,189 -6.7 -22% 9,481 4,481 0 0 -2,081 -2,081 13,844
MamaMancini's Holdings (MMMB) 23,106 32% 21.1 11% 10,462 10,399 24,731 7,963 1,123 1,303 27,501
Nukkleus (NUKK) 23,049 2% -46.5 -136% 324 1,307 19,200 300 -439 -495 23,040
Astro Aerospace (ASDN) 23,044 -3.2 759,640,700% 0 0 -7,596 -7,143 23,019
Blue Eagle Lithium (BEAG) 23,028 -51.1 -47% 967 634 0 0 -451 -451 23,027
GB Sciences (GBLX) 22,981 -23% -1.8 -56% 29,840 15,525 3,909 -891 -16,597 -12,951 23,417
Reviv3 Procare (RVIV) 28,900 44% -191.0 -20% 741 64 993 440 -150 -150 28,554
Cincinnati Bancorp (CNNB) 22,632 2.8 0% 221,474 197,766 0 0 458 2,707 7,626
Trident Brands (TDNT) 22,618 18% -4.5 -128% 5,394 24,698 2,093 371 -6,884 -4,623 20,964
Synergy CHC (SNYR) 22,472 71% 9.6 11% 16,623 10,696 23,170 16,532 1,894 2,827 27,247
Hedgepath Pharmaceuticals (HPPI) 22,227 -9.9 -141% 1,484 3,359 0 0 -2,098 -2,098 20,855
CafePress (PRSS) 22,127 40% -4.1 -21% 36,635 7,335 76,314 30,369 -7,780 -3,082 12,657
Renmin Tianli (ABAC) 22,074 10% -11.2 1% 90,826 3,425 26,426 2,713 626 3,526 -39,336

Balance Sheet ($'000)2011-09-302011-12-312012-09-302012-12-312013-06-302013-10-012013-12-312014-06-302014-09-302014-12-312015-03-312015-09-302015-12-312016-06-302016-09-302016-12-312017-06-302017-09-302017-12-312018-03-312018-06-302018-12-312019-03-312019-09-30
Cash90018003,2131,6382820345671782,0729911,4559711,4873,5804,65932422885
Accounts Receivable150501069686868248553667907430488187
Inventory32735336071,0491,4132,8332,1371,542
PP&E3636363600781456999831,5871,8953,2286,8257,6848,60511,29611,73215,22316,25023,11925,86810,265
Assets6349424225533,3122,0131,5861,4512,2842,3373,5609,3239,12311,85515,16016,39724,05028,26230,63530,02329,840
Accounts Payable0423111134212446771,0961,1517631481264576933722982,2703,0711,621
Long-Term Debt2,0202,0954731355314225521521
Liabilities1,7311,7519648741,2569631,144616-55411,2052,8413,5804,2237,2405,4824,4307,4957,9218,4188,37411,26412,86715,525
Stockholders' Equity-1,669-1,702-922-832-1,232-958-1,1412,6962,0181,148246-557-1,244-6162,0733,5847,3167,5358,47612,74913,38910,3308,3005,288
Income Statement ($'000)2011-09-302011-12-312012-09-302012-12-312013-06-302013-10-012013-12-312014-06-302014-09-302014-12-312015-03-312015-09-302015-12-312016-06-302016-09-302016-12-312017-06-302017-09-302017-12-312018-03-312018-06-302018-12-312019-03-312019-09-30
Revenue00000000000000541371,2758751,3156967261,172
Cost of Revenue0000000003882255813032,0601,857
Gross Profit000000000887650735393-1,334-685
R&D
SG&A221818614135621,780678-11,9272,6931,1291,2082,1983,2152,8752,7797,1076,7754,4642,9833,7871,403
Tax738-211-57
Net Income-75-34-3190274-183-1,445-1,670-622-3,986-2,681-1,097-1,341-2,467-3,524-3,082-3,145-6,962-9,779-5,167-3,763-4,983-2,683
Cash Flow ($'000)2011-09-302011-12-312012-09-302012-12-312013-06-302013-10-012013-12-312014-06-302014-09-302014-12-312015-03-312015-09-302015-12-312016-06-302016-09-302016-12-312017-06-302017-09-302017-12-312018-03-312018-06-302018-12-312019-03-312019-09-30
Cash Operating-9-11-5-939-1,507-869-231-958-735-1,148-2,190-3,061-2,771-4,225-3,496-1,708
Cash Investing000-29-69-557-8-892-87-1,024-138-510-829-3,927-2,662-1,138
Cash Financing01153,842071-441,9942,7161,0911,0903,0884,11610,2457,2372,749